Observed and expected deaths by cause and SMR for all PVC cohort members
| Cause of death (ICD9) | Observed | Expected | SMR (95% CI) |
|---|---|---|---|
| *Significant at 5% level. | |||
| †Other gastrointestinal sites including oesophagus, small intestine, and pancreas. | |||
| All causes (1–999) | 144 | 185.9 | 0.78 (0.65 to 0.91)* |
| All cancers (140–209) | 57 | 43.7 | 1.30 (0.99 to 1.69) |
| Cancer of lip, oral cavity, and pharynx (140–149) | 4 | 6.6 | 0.60 (0.16 to 1.55) |
| Cancer of digestive system (150–159) | 37 | 24.1 | 1.54 (1.08 to 2.12)* |
| Malignant neoplasm of stomach (151) | 6 | 3.3 | 1.83 (0.67 to 3.99) |
| Malignant neoplasm of colon and rectum (153, 154) | 3 | 2.8 | – |
| Malignant neoplasm of liver (155) | 25 | 14.1 | 1.78 (1.15 to 2.62)* |
| Malignant neoplasm of other GI sites† (150, 152, 157) | 3 | 2.9 | – |
| Cancer of respiratory system (160–165) | 4 | 6.7 | 0.59 (0.16 to 1.52) |
| Cancer of genitourinary system (179–189) | 2 | 1.2 | – |
| Malignant neoplasm of brain (191) | 2 | 0.7 | – |
| Cancer of lymphatic and haematopoietic tissue (200–208) | 7 | 2.6 | 2.71 (1.09 to 5.60)* |
| Lymphoid leukaemia (204) | 2 | 0.2 | – |
| Diabetes mellitus (250) | 3 | 4.9 | – |
| Diseases of the circulatory system (390–459) | 12 | 35.0 | 0.34 (0.18 to 0.60)* |
| Ischaemic heart disease (410–414) | 4 | 6.0 | 0.66 (0.18 to 1.69) |
| Cerebrovascular disease (430–438) | 4 | 17.6 | 0.23 (0.06 to 0.58)* |
| Diseases of the digestive system (520–579) | 12 | 23.3 | 0.52 (0.26 to 0.90)* |
| Diseases of liver and biliary tract (570–579) | 11 | 21.4 | 0.51 (0.26 to 0.92)* |
| Chronic liver disease and cirrhosis (571) | 7 | 16.4 | 0.42 (0.17 to 0.88)* |
| Diseases of the genitourinary system (580–589) | 3 | 3.2 | – |
| Unknown (797–799) | 6 | 6.1 | 0.98 (0.36 to 2.13) |
| Injury and poisoning (800–999) | 36 | 48.8 | 0.74 (0.52 to 1.02) |